US Patent 8318160 Treatment of cancer with novel anti-IL13 monoclonal antibodies

Patent 8318160 was granted and assigned to Genentech on November, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

83181600

Patent Inventor Names

Matthew Moyle0

Sek Chung Fung0

Date of Patent

November 27, 2012

Patent Application Number

126876370

Date Filed

January 14, 2010

Patent Citations Received

‌

US Patent 11667706 Methods of purifying recombinant anti-abeta antibodies

‌

US Patent 11760797 Anti-interleukin-33 antibodies and uses thereof

Patent Primary Examiner

‌

Peter J Reddig

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8318160 Treatment of cancer with novel anti-IL13 monoclonal antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API